expert roundtables

Most Effective Outcome Measures for Assessing Treatment Response in Relapsed/Refractory Chronic Lymphocytic Leukemia
Oncology

Most Effective Outcome Measures for Assessing Treatment Response in Relapsed/Refractory Chronic Lymphocytic Leukemia

expert roundtables
By Bruce D. Cheson, MD, FACP, FAAAS, FASCO; Jennifer R. Brown, MD, PhD
Recommendations for the Use of Maintenance and Consolidation Therapy in Chronic Lymphocytic Leukemia
Oncology

Recommendations for the Use of Maintenance and Consolidation Therapy in Chronic Lymphocytic Leukemia

expert roundtables
By Bruce D. Cheson, MD, FACP, FAAAS, FASCO; Jennifer R. Brown, MD, PhD
Pathobiology-Guided Therapy in Rheumatoid Arthritis
Rheumatology

Pathobiology-Guided Therapy in Rheumatoid Arthritis

expert roundtables
By Eric M. Ruderman, MD; Jeffrey R. Curtis, MD, MS, MPH; Leonard H. Calabrese, DO
Facing the Challenge of Persistent Moderate Disease Activity Despite Biologic Therapy
Rheumatology

Facing the Challenge of Persistent Moderate Disease Activity Despite Biologic Therapy

expert roundtables
By Eric M. Ruderman, MD; Jeffrey R. Curtis, MD, MS, MPH; Leonard H. Calabrese, DO
Use of Prognostic Factors to Guide the Treatment of Patients With Mantle Cell Lymphoma
Oncology

Use of Prognostic Factors to Guide the Treatment of Patients With Mantle Cell Lymphoma

expert roundtables
By Brad Kahl, MD; Julie M. Vose, MD, MBA, FASCO; Thomas J. Kipps, MD, PhD
Load More